1-19 of 19
Harry D. Bear
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 7664: Early detection of racial disparity and treatment resistance in triple negative breast cancer

Amy H. Tang, Richard A. Hoefer, Mary L. Guye, Billur Samli, Janet S. Winston, Jennifer Koblinski, Valentina Robila, Michael O. Idowu, Rick J. Jansen, Harry D. Bear
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 7664.
https://doi.org/10.1158/1538-7445.AM2024-7664
Published: 22 March 2024
View article titled, Abstract 7664: Early detection of racial disparity and treatment resistance in triple negative breast cancer
Journal Articles

Abstract 6521: Macrophage-targeting immunotherapy enhances chemotherapy response in primary and metastatic triple-negative breast cancer models

Matthew Emilio Fernandez, Yasir Alshehry, Laura Graham, Jennifer E. Koblinski, Harry D. Bear, Doug H. Sweet, Sandro R. da Rocha
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 6521.
https://doi.org/10.1158/1538-7445.AM2024-6521
Published: 22 March 2024
View article titled, Abstract 6521: Macrophage-targeting immunotherapy enhances chemotherapy response in primary and metastatic triple-negative breast cancer models
Journal Articles

Abstract 2328: Macrophage-targeting immunotherapy for triple negative breast cancer

Matthew E. Fernandez, Cory B. Fines, Fatemah S. Subul, Sulaiman S. Alhudaithi, Harry D. Bear, Douglas H. Sweet, Sandro R. da Rocha
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 2328.
https://doi.org/10.1158/1538-7445.AM2023-2328
Published: 04 April 2023
View article titled, Abstract 2328: Macrophage-targeting immunotherapy for triple negative breast cancer
Journal Articles

Abstract 5531: Early detection of cancer disparity and treatment resistance in TNBC

Amy H. Tang, Richard A. Hoefer, Dasom Lee, Emily L. Breeding, Mary L. Guye, Janet S. Winston, Billur Samli, Jennifer Koblinski, Valentina Robila, Michael O. Idowu, Rick J. Jansen, Harry D. Bear
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 5531.
https://doi.org/10.1158/1538-7445.AM2023-5531
Published: 04 April 2023
View article titled, Abstract 5531: Early detection of cancer disparity and treatment resistance in TNBC
Journal Articles

Abstract HER2-06: HER2-06 Outcome analysis of HER2-zero or HER2-low hormone receptor-positive (HR+) breast cancer patients - characterization of the molecular phenotype in combination with molecular subtyping

Carsten Denkert, Miguel Martín, Michael Untch, Hervé R. Bonnefoi, Erik S. Knudsen, Seock-Ah Im, Angela DeMichele, Agnieszka Witkiewicz, Laura Van ’t Veer, Sung-Bae Kim, Harry D. Bear, Nicole McCarthy, Karen Gelmon, Frederik Marmé, José Ángel García-Sáenz, Nicholas Turner, Federico Rojo, Martin Filipits, Lesley-Ann Martin, Peter A. Fasching, Christian Schem, Catherine M. Kelly, Toralf Reimer, Masakazu Toi, Hope Rugo, Michael Gnant, Andreas Makris, Yuan Liu, Karsten Weber, Sivaramakrishna Rachakonda, Sibylle Loibl
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): HER2-06.
https://doi.org/10.1158/1538-7445.SABCS22-HER2-06
Published: 01 March 2023
View article titled, Abstract HER2-06: HER2-06 Outcome analysis of HER2-zero or HER2-low hormone receptor-positive (HR+) breast cancer patients - characterization of the molecular phenotype in combination with molecular subtyping
Journal Articles

Abstract PD17-06: Immunohistochemical markers and determinants of clinical response in the Penelope-B trial

Erik S. Knudsen, Sivaramakrishna Rachakonda, Frederik Marmé, Miguel Martín, Michael Untch, Hervé R. Bonnefoi, Wolfgang D. Schmitt, Sung-Bae Kim, Harry D. Bear, Agnieszka Witkiewicz, Seock-Ah Im, Angela DeMichele, Laura Van’t Veer, Nicole McCarthy, Bruno V. Sinn, Karen Gelmon, José Ángel García-Sáenz, Catherine M. Kelly, Toralf Reimer, Nicholas Turner, Federico Rojo, Martin Filipits, Peter A. Fasching, Christian Schem, Lesley-Ann Martin, Yuan Liu, Masakazu Toi, Hope Rugo, Michael Gnant, Andreas Makris, Jenny Furlanetto, Karsten Weber, Carsten Denkert, Sibylle Loibl
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): PD17-06.
https://doi.org/10.1158/1538-7445.SABCS22-PD17-06
Published: 01 March 2023
View article titled, Abstract PD17-06: Immunohistochemical markers and determinants of clinical response in the Penelope-B trial
Journal Articles

Engineering T Cells to Express Tumoricidal MDA-7/IL24 Enhances Cancer Immunotherapy

Zheng Liu, Chunqing Guo, Swadesh K. Das, Xiaofei Yu, Anjan K. Pradhan, Xia Li, Yanxia Ning, Shixian Chen, Wenjie Liu, Jolene J. Windle, Harry D. Bear, Masoud H. Manjili, Paul B. Fisher, Xiang-Yang Wang
Journal: Cancer Research
Cancer Res (2021) 81 (9): 2429–2441.
https://doi.org/10.1158/0008-5472.CAN-20-2604
Published: 01 May 2021
View article titled, Engineering T Cells to Express Tumoricidal MDA-7/IL24 Enhances Cancer Immunotherapy
Open the PDF for Engineering T Cells to Express Tumoricidal MDA-7/IL24 Enhances Cancer Immunotherapy in another window
Includes: Supplementary data
Journal Articles

Abstract GS1-07: Effects of capecitabine as part of neo-/adjuvant chemotherapy. A meta-analysis of individual patient data from 12 randomized trials including 15,457 patients

Marion van Mackelenbergh, Fenja Seither, Volker Möbus, Joyce O'Shaugnessy, Miguel Martin, Heikki Joenssuu, Michael Untch, Ulrike Nitz, Juan J Miralles, Masakazu Toi, Harry D Bear, Hymann Muss, Toralf Reimer, Valentina Nekljudova, Sibylle Loibl
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): GS1-07.
https://doi.org/10.1158/1538-7445.SABCS19-GS1-07
Published: 15 February 2020
View article titled, Abstract GS1-07: Effects of capecitabine as part of neo-/adjuvant chemotherapy. A meta-analysis of individual patient data from 12 randomized trials including 15,457 patients
Journal Articles

Abstract 2145: Detect early tumor relapse in high-risk breast cancer

Amy H. Tang, Lauren L. Siewertsz van Reesema, Vasilena P. Zheleva, Janet S. Winston, Rick J. Jansen, Emanuel F. Petricoin, Matthew P. Goetz, Matthew P. Goetz, Harry D. Bear, Richard A. Hoefer
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 2145.
https://doi.org/10.1158/1538-7445.AM2019-2145
Published: 01 July 2019
View article titled, Abstract 2145: Detect early tumor relapse in high-risk breast cancer
Journal Articles

Abstract PD2-1: The effect on overall and disease-free survival (OS & DFS) by adding bevacizumab and/or antimetabolites to standard neoadjuvant chemotherapy: NSABP Protocol B-40

Harry D Bear, Gong Tang, Priya Rastogi, Charles E Geyer, Qing Liu, André Robidoux, James N Atkins, Luis Baez-Diaz, Adam M Brufsky, Rita S Mehta, Louis Fehrenbacher, James A Young, Francis M Senecal, Rakesh Gaur, Richard G Margolese, Paul T Adams, Howard M Gross, Joseph P Costantino, Soonmyung Paik, Sandra M Swain, Eleftherios P Mamounas, Norman Wolmark
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): PD2-1.
https://doi.org/10.1158/1538-7445.SABCS14-PD2-1
Published: 01 May 2015
View article titled, Abstract PD2-1: The effect on overall and disease-free survival (OS & DFS) by adding bevacizumab and/or antimetabolites to standard neoadjuvant chemotherapy: NSABP Protocol B-40
Journal Articles

Abstract 116: Methylcytosine binding domain protein 2(MBD2) dependent proliferation and survival of breast cancer cells

Omar Y. Mian, Shou Z. Wang, Sheng Z. Zhu, Harry D. Bear, Gordon D. Ginder
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 116.
https://doi.org/10.1158/1538-7445.AM2011-116
Published: 15 April 2011
View article titled, Abstract 116: Methylcytosine binding domain protein 2(MBD2) dependent proliferation and survival of breast cancer cells
Journal Articles

Abstract 775: Sequential common gamma-chain cytokines facilitate differentiation of tumor-reactive T cells that are resistant to MDSC and can induce rejection of breast tumors

Kyle K. Payne, Maciej Kmieciak, Debasmita Basu, Viswanathan Ramakrishnan, Harry D. Bear, Masoud H. Manjili
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 775.
https://doi.org/10.1158/1538-7445.AM2011-775
Published: 15 April 2011
View article titled, Abstract 775: Sequential common gamma-chain cytokines facilitate differentiation of tumor-reactive T cells that are resistant to MDSC and can induce rejection of breast tumors
Journal Articles

Signatures Associated with Rejection or Recurrence in HER-2/neu–Positive Mammary Tumors

Andrea Worschech, Maciej Kmieciak, Keith L. Knutson, Harry D. Bear, Aladar A. Szalay, Ena Wang, Francesco M. Marincola, Masoud H. Manjili
Journal: Cancer Research
Cancer Res (2008) 68 (7): 2436–2446.
https://doi.org/10.1158/0008-5472.CAN-07-6822
Published: 01 April 2008
View article titled, Signatures Associated with Rejection or Recurrence in HER-2/<em>neu</em>–Positive Mammary Tumors
Open the PDF for Signatures Associated with Rejection or Recurrence in HER-2/<em>neu</em>–Positive Mammary Tumors in another window
Includes: Supplementary data
Journal Articles

Adoptive immunotherapy (AIT) of established tumors with tumor antigen peptide-sensitized T cells

Catriona T. Miller, Laura J. Graham, Harry D. Bear
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 1264.
Published: 01 April 2004
View article titled, Adoptive immunotherapy (AIT) of established tumors with tumor antigen peptide-sensitized T cells
Journal Articles

γ-Interferon Plays a Key Role in T-Cell-induced Tumor Regression

Todd M. Tuttle, Carl W. McCrady, Thomas H. Inge, Mozhdeh Salour, Harry D. Bear
Journal: Cancer Research
Cancer Res (1993) 53 (4): 833–839.
Published: 01 February 1993
View article titled, γ-Interferon Plays a Key Role in T-Cell-induced Tumor Regression
Open the PDF for γ-Interferon Plays a Key Role in T-Cell-induced Tumor Regression in another window
Journal Articles

Inhibition of Tumor-specific Cytotoxic T-Lymphocyte Responses by Transforming Growth Factor β1

Thomas H. Inge, Shelley K. Hoover, Brian M. Susskind, Sandra K. Barrett, Harry D. Bear
Journal: Cancer Research
Cancer Res (1992) 52 (6): 1386–1392.
Published: 01 March 1992
View article titled, Inhibition of Tumor-specific Cytotoxic T-Lymphocyte Responses by Transforming Growth Factor β<sub>1</sub>
Open the PDF for Inhibition of Tumor-specific Cytotoxic T-Lymphocyte Responses by Transforming Growth Factor β<sub>1</sub> in another window
Journal Articles

Activation and Growth of Murine Tumor-specific T-Cells Which Have in Vivo Activity with Bryostatin 1

Todd M. Tuttle, Thomas H. Inge, Kevin P. Bethke, Carl W. McCrady, George R. Pettit, Harry D. Bear
Journal: Cancer Research
Cancer Res (1992) 52 (3): 548–553.
Published: 01 February 1992
View article titled, Activation and Growth of Murine Tumor-specific T-Cells Which Have <em>in Vivo</em> Activity with Bryostatin 1
Open the PDF for Activation and Growth of Murine Tumor-specific T-Cells Which Have <em>in Vivo</em> Activity with Bryostatin 1 in another window
Journal Articles

Phenotype of Syngeneic Tumor-specific Cytotoxic T-Lymphocytes and Requirements for Their in Vitro Generation from Tumor-bearing Host and Immune Spleens

Harry D. Bear, Brian M. Susskind, Karen A. Close, Sandra K. Barrett
Journal: Cancer Research
Cancer Res (1988) 48 (6): 1422–1427.
Published: 01 March 1988
View article titled, Phenotype of Syngeneic Tumor-specific Cytotoxic T-Lymphocytes and Requirements for Their <em>in Vitro</em> Generation from Tumor-bearing Host and Immune Spleens
Open the PDF for Phenotype of Syngeneic Tumor-specific Cytotoxic T-Lymphocytes and Requirements for Their <em>in Vitro</em> Generation from Tumor-bearing Host and Immune Spleens in another window
Journal Articles

Tumor-specific Suppressor T-Cells Which Inhibit the in Vitro Generation of Cytolytic T-Cells from Immune and Early Tumor-bearing Host Spleens

Harry D. Bear
Journal: Cancer Research
Cancer Res (1986) 46 (4_Part_1): 1805–1812.
Published: 01 April 1986
View article titled, Tumor-specific Suppressor T-Cells Which Inhibit the <em>in Vitro</em> Generation of Cytolytic T-Cells from Immune and Early Tumor-bearing Host Spleens
Open the PDF for Tumor-specific Suppressor T-Cells Which Inhibit the <em>in Vitro</em> Generation of Cytolytic T-Cells from Immune and Early Tumor-bearing Host Spleens in another window